Immunotherapy For Prostate Cancer Clinics Abroad — Page 4

Global Hospital Chennai has the Da Vinci surgical robot for precise procedures and a TrueBeam STx radiotherapy system. The hospital holds dual NABH and Newsweek’s World's Best Hospital accreditation. It is part of the Gleneagles group, treating 2 million patients annually. International services include interpreters and transfers from Chennai airport, 16 km away.

Global Hospital Mumbai is part of the established Gleneagles Global Hospitals Group. Its oncology centre treats 8,000 foreign patients from 25 countries annually. Treatment may cost 30–50% less than in Europe or the United States, offering significant savings. The hospital holds NABH accreditation for international quality standards and NABL accreditation for lab accuracy. The International Patients Service provides airport transfers and interpreter services.

Manipal Goa Hospital uses IBM Watson for Oncology – an AI providing personalised treatment recommendations with 96% accuracy. Treatment may cost 2–5 times less than in Western Europe, and the all-inclusive package typically covers airport transfers, interpreter services, accommodation, and meals. The NABH-accredited centre follows American treatment protocols and has extensive experience serving international patients.

Seoul National University Hospital – Korea's top-rated facility – has a prostate cancer surgery success rate of 96.6%. Its Cancer Centre runs around 150 clinical trials annually, offering access to advanced immunotherapy research. The hospital treats 30,000 international patients yearly, with dedicated multilingual support and English digital health records for seamless follow-up back home. The established International Department coordinates care for Australians.

HCG Manavata Cancer Centre is Maharashtra's first NABH-accredited cancer hospital, meeting international standards for patient safety and care. It treats over 75,000 patients annually, reflecting deep experience in complex oncology cases. The centre is first in the region to offer advanced radiotherapy like TomoTherapy-H and Versa HD for precise, targeted treatment. Dr Shruti Kate, a Medical Oncologist trained at Tata Memorial Hospital, specialises in immunotherapy for genitourinary cancers including prostate cancer. The affiliated Manavata Clinical Research Institute is audited by US-FDA, providing access to cutting-edge clinical trials.